BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18021936)

  • 21. Effects of bone morphogenic proteins and transforming growth factor-beta on In-vitro production of endothelin-1 by human pulmonary microvascular endothelial cells.
    Star GP; Giovinazzo M; Langleben D
    Vascul Pharmacol; 2009; 50(1-2):45-50. PubMed ID: 18849010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification.
    Sakou T; Onishi T; Yamamoto T; Nagamine T; Sampath Tk; Ten Dijke P
    J Bone Miner Res; 1999 Jul; 14(7):1145-52. PubMed ID: 10404014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary pulmonary hypertension: molecular basis and potential for therapy.
    Rudarakanchana N; Morrell NW
    Expert Rev Mol Med; 2004 Mar; 6(6):1-15. PubMed ID: 15005857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [BMP in the kidney: signaling, function and pathophysiological significance].
    Hanai J
    Clin Calcium; 2007 May; 17(5):704-10. PubMed ID: 17470999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension.
    Machado RD; James V; Southwood M; Harrison RE; Atkinson C; Stewart S; Morrell NW; Trembath RC; Aldred MA
    Circulation; 2005 Feb; 111(5):607-13. PubMed ID: 15699281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel mutation in the BMPR2 gene in familial pulmonary arterial hypertension.
    Fu LJ; Zhou AQ; Huang MR; Shen SH; Shen J; Zhang ZF; Li F
    Chin Med J (Engl); 2008 Mar; 121(5):399-404. PubMed ID: 18364108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics of pulmonary arterial hypertension: current and future implications.
    Elliott CG
    Semin Respir Crit Care Med; 2005 Aug; 26(4):365-71. PubMed ID: 16121312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of the BMPR2 gene in patients with pulmonary arterial hypertension].
    Portillo K; Santos S; Madrigal I; Blanco I; Paré C; Borderías L; Peinado VI; Roca J; Milà M; Barberà JA
    Arch Bronconeumol; 2010 Mar; 46(3):129-34. PubMed ID: 20096498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and molecular genetic features of hereditary pulmonary arterial hypertension.
    Brenner L; Chung WK
    Compr Physiol; 2011 Oct; 1(4):1721-8. PubMed ID: 23733703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idiopathic pulmonary hypertension: what did we learn from genes?
    Sztrymf B; Yaïci A; Jaïs X; Sitbon O; Simonneau G; Humbert M
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S91-100. PubMed ID: 16457021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mouse through the looking glass: a new door into the pathophysiology of pulmonary hypertension.
    Rabinovitch M
    Circ Res; 2004 Apr; 94(8):1001-4. PubMed ID: 15117827
    [No Abstract]   [Full Text] [Related]  

  • 32. The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
    Happé C; Kurakula K; Sun XQ; da Silva Goncalves Bos D; Rol N; Guignabert C; Tu L; Schalij I; Wiesmeijer KC; Tura-Ceide O; Vonk Noordegraaf A; de Man FS; Bogaard HJ; Goumans MJ
    Cells; 2020 Jun; 9(6):. PubMed ID: 32521690
    [No Abstract]   [Full Text] [Related]  

  • 33. Impaired transforming growth factor-beta signaling in idiopathic pulmonary arterial hypertension.
    Richter A; Yeager ME; Zaiman A; Cool CD; Voelkel NF; Tuder RM
    Am J Respir Crit Care Med; 2004 Dec; 170(12):1340-8. PubMed ID: 15361368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.
    ; Lane KB; Machado RD; Pauciulo MW; Thomson JR; Phillips JA; Loyd JE; Nichols WC; Trembath RC
    Nat Genet; 2000 Sep; 26(1):81-4. PubMed ID: 10973254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics and genomics of pulmonary arterial hypertension.
    Machado RD; Eickelberg O; Elliott CG; Geraci MW; Hanaoka M; Loyd JE; Newman JH; Phillips JA; Soubrier F; Trembath RC; Chung WK
    J Am Coll Cardiol; 2009 Jun; 54(1 Suppl):S32-S42. PubMed ID: 19555857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic aspects of pulmonary arterial hypertension.
    Morse JH; Deng Z; Knowles JA
    Ann Med; 2001 Dec; 33(9):596-603. PubMed ID: 11817654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance linked to functional defects in bone morphogenetic protein type 2 receptor, BMPR2.
    Kim MJ; Park SY; Chang HR; Jung EY; Munkhjargal A; Lim JS; Lee MS; Kim Y
    BMB Rep; 2017 Jun; 50(6):308-317. PubMed ID: 28391780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Idiopathic pulmonary arterial hypertension associated with a novel frameshift mutation in the bone morphogenetic protein receptor II gene and enhanced bone morphogenetic protein signaling: A case report.
    Choi SH; Jung YK; Jang JA; Han S
    Medicine (Baltimore); 2019 Oct; 98(42):e17594. PubMed ID: 31626133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BMP-dependent activation of caspase-9 and caspase-8 mediates apoptosis in pulmonary artery smooth muscle cells.
    Lagna G; Nguyen PH; Ni W; Hata A
    Am J Physiol Lung Cell Mol Physiol; 2006 Nov; 291(5):L1059-67. PubMed ID: 17030903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGF-β and BMPR2 Signaling in PAH: Two Black Sheep in One Family.
    Rol N; Kurakula KB; Happé C; Bogaard HJ; Goumans MJ
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30200294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.